AT Uro Congress
May 22-24, 2025
Vienna, Austria
News and Events
Subscribe to our press distribution list to receive the latest news about AMW.
Upcoming
Events
EuroPLX
June 2-3, 2025
Lisbon, Portugal
CPHI South East Asia 2025
July 16-18, 2025
Kuala Lumpur, Malaysia
https://www.cphi.com/sea/en/home.html
CPHI 2025
October 28-30, 2025
Frankfurt, Germany
https://www.cphi.com/europe/en/home.html
BIO-Europe 2025
November 3-5, 2025
Vienna, Austria
https://informaconnect.com/bioeurope/
Past
Events
Archive
Pharmapack
January 24-25, 2024 Paris, France https://www.pharmapackeurope.com/
read morePharmasynergy
February 08-09, 2024
London, UK
euroPLX84
February 26-27, 2024 Lisbon, Portugal
read moreBIO-Europe Spring
March 18-20, 2024
Barcelona, Spain
https://informaconnect.com/bioeurope-spring/
4th Wet AMD & Diabetic Eye Disease Drug Development
March 19-21, 2024
Boston, MA
https://wet-amd-drug-development.com/
BIO International Convention
June 03-06, 2024
San Diego, California
https://www.bio.org/events/bio-international-convention
CPHI South East Asia
July 10-12, 2024 Bangkok, Thailand https://www.cphi.com/sea/en/home.html
read moreCPHI 2024
October 08-10, 2024 Milan, Italy https://www.cphi.com/europe/en/home.html
read morePODD – Partnership Opportunities in Drug Delivery
October 28-29, 2024 Boston, USA https://poddconference.com
read moreBIO-Europe
November 04-06, 2024 Stockholm, Sweden https://informaconnect.com/bioeurope/
read morePharmaSynergyRx 2025
February 27-28, 2025
London, UK
https://pharma-synergy-conference.com/pharmasynergy-2025/
BIO-Europe Spring
March 17-19, 2025
Milan, Italy
https://informaconnect.com/bioeurope-spring/
DCAT Week 2025
March 17-20, 2025
New York City, USA
https://dcatweek.org/
Latest
News
AMW Reports Another Record Result for the 2024 Financial Year
Warngau, Germany, May 13, 2025 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, today reported financial results for the year ended December 31, 2024. AMW posted another consolidated record revenue for 2024 of EUR 38.2 million, an increase of 30% compared to the previous year (2023: EUR 29.4 million). The […]
read moreAMW Pioneers Use of Artificial Intelligence in Formulation Development
Warngau, February 25, 2025 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, today announced the launch of a research and development project to optimize formulation development using artificial intelligence (AI). The working group of Prof. Dr. Olivia Merkel, Chair of Drug Delivery at the Department of Pharmacy at Ludwig-Maximilians-Universität (LMU) […]
read moreAMW Appoints Additional Experts for Drug Delivery Systems to its Scientific Advisory Board
Warngau, Germany, July 1, 2024 AMW GmbH, a specialty bio-pharmaceutical company focused on innovative sustained-release drug delivery systems, today announced the appointment of Prof. Miriam Breunig, Senior Academic Councillor at the University of Regensburg’s Department of Pharmaceutical Technology, and Prof. Karsten Mäder, Professor of Pharmaceutics at Martin Luther University Halle-Wittenberg, as members to AMW’s Scientific […]
read moreAMW Again Reports Record Financial Results 2023, CEO Philipp Karbach Becomes Shareholder, Investment Program For Employees Launched
Warngau, June 3, 2024 AMW GmbH, a specialty bio-pharmaceutical company focused on innovative sustained-release drug delivery systems, today reported financial results for the year ended December 31, 2023. AMW posted a 2023 consolidated record revenue of EUR 29.4 million and achieved operating profitability for the second consecutive year. In addition, the Company reported a partial […]
read moreAMW Receives Notified Body Opinion by TÜV SÜD for its Leuprorelin Implant in Pre-Filled Syringe
Warngau, Germany, May 15, 2024 AMW GmbH, a bio-pharmaceutical company specializing in innovative drug delivery systems, announced today that it has received the final Notified Body Opinion (NBO) report for its leuprorelin implant in prefilled syringes. The NBO completes a diligent conformity review procedure by a notified body, in this case TÜV SÜD. Following official […]
read more